As the seven-member angiopoietin-like proteins (ANGPTL) family had been previously shown to promote the hemopoietic repopulation ability of HSCs acting through LILRB2 and PIRB [51, 52], the effects of this signaling axis were examined in AML. The gene discussed is LILRB2; the disease is acute myeloid leukemia.